SECsense Logo

Dexcom, Inc. 8-K Report: Key Updates on Financial Developments - May 2025

$DXCM
Form 8-K
Filed on: 2025-05-09
Source
Dexcom, Inc. 8-K Report: Key Updates on Financial Developments - May 2025

Based on the extracted section of the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Dexcom, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK Number: 0001093557
  • IRS Employer Identification Number: 33-0857544
  • Headquarters Address: 6340 Sequence Drive, San Diego, CA 92121
  • Contact Number: 858-200-0200
  1. Filing Information:
  • Form Type: 8-K
  • Filing Date: May 8, 2025
  1. Stock Information:
  • Class of Securities: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: DXCM
  • Stock Exchange: NASDAQ
  1. Period of Reporting:
  • Report Date: May 8, 2025 (indicating this may be an event-driven report).

Insights:

  • This report is a Form 8-K, which indicates that it is likely disclosing significant events or changes at Dexcom, Inc. It is essential for investors and analysts to pay attention to the specific contents of this filing for any material developments.
  • The company operates in the medical technology sector, known for its continuous glucose monitoring systems, which could be relevant for both market analysis and investment considerations.
  • The contact information and location suggest accessibility for investors and stakeholders who may want to inquire further or seek additional information about the company's operations.

Overall, the filing reflects a standard update from a publicly traded company, and the specifics of the report would need to be reviewed for detailed insights into any significant business changes or financial performance indicators.